Sandra Turner

4.8k total citations · 1 hit paper
109 papers, 2.9k citations indexed

About

Sandra Turner is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sandra Turner has authored 109 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Pulmonary and Respiratory Medicine, 31 papers in Radiation and 30 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sandra Turner's work include Prostate Cancer Diagnosis and Treatment (42 papers), Prostate Cancer Treatment and Research (37 papers) and Advanced Radiotherapy Techniques (31 papers). Sandra Turner is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (42 papers), Prostate Cancer Treatment and Research (37 papers) and Advanced Radiotherapy Techniques (31 papers). Sandra Turner collaborates with scholars based in Australia, New Zealand and United Kingdom. Sandra Turner's co-authors include Nigel Spry, Gillian Duchesne, David Joseph, James W. Denham, Chris Atkinson, David Christie, David S. Lamb, Allison Steigler, Keen‐Hun Tai and Catherine D’Este and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Lancet Oncology.

In The Last Decade

Sandra Turner

102 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial

2011 299 citations James W. Denham, David S. Lamb et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra Turner Australia	28	1.7k	958	664	533	470	109	2.9k
Karen E. Hoffman United States	35	2.9k 1.7×	611 0.6×	873 1.3×	399 0.7×	780 1.7×	135	3.9k
Bridget F. Koontz United States	27	1.9k 1.1×	356 0.4×	904 1.4×	452 0.8×	442 0.9×	106	2.6k
Per Fransson Sweden	19	1.8k 1.1×	423 0.4×	672 1.0×	366 0.7×	607 1.3×	80	2.4k
Gillian Duchesne Australia	36	3.1k 1.8×	1.2k 1.2×	1.7k 2.5×	1.1k 2.0×	905 1.9×	159	4.8k
Ewa Szumacher Canada	26	1.0k 0.6×	469 0.5×	496 0.7×	323 0.6×	424 0.9×	92	2.0k
Brent S. Rose United States	28	1.2k 0.7×	766 0.8×	412 0.6×	424 0.8×	807 1.7×	171	2.6k
Arul Mahadevan United States	17	2.7k 1.6×	534 0.6×	1.2k 1.8×	526 1.0×	450 1.0×	22	3.2k
Tom Pickles Canada	47	4.5k 2.7×	950 1.0×	1.3k 2.0×	640 1.2×	1.2k 2.5×	196	6.1k
Brandon A. Mahal United States	36	2.1k 1.2×	542 0.6×	258 0.4×	369 0.7×	1.8k 3.8×	158	3.9k
Charles Hayter Canada	24	932 0.6×	568 0.6×	505 0.8×	325 0.6×	509 1.1×	56	2.0k

Countries citing papers authored by Sandra Turner

Since Specialization

Citations

This map shows the geographic impact of Sandra Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Turner more than expected).

Fields of papers citing papers by Sandra Turner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Turner. The network helps show where Sandra Turner may publish in the future.

Co-authorship network of co-authors of Sandra Turner

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Turner. A scholar is included among the top collaborators of Sandra Turner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Turner. Sandra Turner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yufeng, Niluja Thiruthaneeswaran, Lois Holloway, et al.. (2025). Longitudinal quantitative MRI in prostate cancer after radiation therapy with and without androgen deprivation therapy. Magnetic Resonance Imaging. 122. 110431–110431.

Laidsaar‐Powell, Rebekah, Phyllis Butow, Sandra Turner, et al.. (2024). An online intervention to improve oncology health professional self-efficacy in communicating with carers: Hybrid effectiveness-implementation evaluation of the eTRIO program. Patient Education and Counseling. 124. 108251–108251.

Balakrishnar, Bavanthi, Megan Crumbaker, Sandra Turner, et al.. (2021). Patterns of care and outcomes of men with germ cell tumors in a high‐volume Australian center. Asia-Pacific Journal of Clinical Oncology. 18(2). e23–e31. 1 indexed citations

Juraskova, Ilona, Rebekah Laidsaar‐Powell, Penelope Schofield, et al.. (2021). eTRIO trial: study protocol of a randomised controlled trial of online education modules to facilitate effective family caregiver involvement in oncology. BMJ Open. 11(5). e043224–e043224. 9 indexed citations

Kneebone, Andrew, Val Gebski, Viet Do, et al.. (2018). Long‐term outcomes in 1121 Australian prostate cancer patients treated with definitive radiotherapy. Journal of Medical Imaging and Radiation Oncology. 63(1). 116–123. 2 indexed citations

Turner, Sandra, Theresa Trotter, Meredith Giuliani, et al.. (2017). Defining a Leader Role curriculum for radiation oncology: A global Delphi consensus study. Radiotherapy and Oncology. 123(2). 331–336. 26 indexed citations

Tesson, Stephanie, Puma Sundaresan, Phyllis Butow, et al.. (2016). Knowledge, attitudes and decision-making preferences of men considering participation in the TROG RAVES Prostate Cancer Trial (TROG 08.03). Radiotherapy and Oncology. 119(1). 84–90. 3 indexed citations

Duchesne, Gillian, Julie K. Bassett, Catherine D’Este, et al.. (2015). TROG 03.06 and VCOG PR 01-03: The "timing of androgen deprivation therapy in prostate cancer patients with a rising PSA (TOAD)" collaborative randomised phase III trial.. Journal of Clinical Oncology. 33(15_suppl). 5007–5007. 9 indexed citations

Turner, Sandra, Jesper Grau Eriksen, Theresa Trotter, et al.. (2015). Establishing a Global Radiation Oncology Collaboration in Education (GRaCE): Objectives and priorities. Radiotherapy and Oncology. 117(1). 188–192. 14 indexed citations

10.

Foroudi, Farshad, Daniel Pham, Aldo Rolfo, et al.. (2014). The outcome of a multi-centre feasibility study of online adaptive radiotherapy for muscle-invasive bladder cancer TROG 10.01 BOLART. Radiotherapy and Oncology. 111(2). 316–320. 37 indexed citations

11.

Denham, James W., David Joseph, Nigel Spry, et al.. (2012). Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial. The Lancet Oncology. 13(12). 1260–1270. 46 indexed citations

12.

Gebski, Val, et al.. (2011). Gold seed fiducial markers for prostate radiation therapy: Describing prostate motion. 58(3). 28–31.

13.

Williams, Scott, Gillian Duchesne, Nirdosh Kumar Gogna, et al.. (2006). An international multicenter study evaluating the impact of an alternative biochemical failure definition on the judgment of prostate cancer risk. International Journal of Radiation Oncology*Biology*Physics. 65(2). 351–357. 22 indexed citations

14.

Lamb, David S., James W. Denham, Hedy Mameghan, et al.. (2003). Acceptability of short term neo-adjuvant androgen deprivation in patients with locally advanced prostate cancer. Radiotherapy and Oncology. 68(3). 255–267. 30 indexed citations

15.

Roos, Daniel, Sidney Davis, Sandra Turner, et al.. (2003). Quality assurance experience with the randomized neuropathic bone pain trial (Trans-Tasman Radiation Oncology Group, 96.05). Radiotherapy and Oncology. 67(2). 207–212. 11 indexed citations

16.

Kneebone, Andrew, Sandra Turner, Martin Berry, Burcu Çakır, & Val Gebski. (2003). Australian prostate‐specific antigen outcome and toxicity following radiation therapy for localized prostate cancer. Australasian Radiology. 47(4). 422–427. 7 indexed citations

17.

Vinod, Shalini, et al.. (2002). Part‐time consultants in radiation oncology. Australasian Radiology. 46(4). 396–401. 1 indexed citations

18.

Hruby, George, Howard Gurney, Sandra Turner, et al.. (1999). Long‐Term Follow‐Up of Patients Treated with Intermittent Hormone Therapy for Advanced Prostate Cancer. 1(3). 138–143. 2 indexed citations

19.

Turner, Sandra, K. W. Tiver, & Steven Boyages. (1995). Thyroid dysfunction following radiotherapy for head and neck cancer. International Journal of Radiation Oncology*Biology*Physics. 31(2). 279–283. 65 indexed citations

20.

Turner, Sandra & K. W. Tiver. (1991). Radical Radiotherapy for Carcinoma of The Larynx ‐Westmead Hospital Experience. Australasian Radiology. 35(3). 242–247. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact